Chapter 2 40 72. Tannenbaum C, Greaves L, Graham ID. Why sex and gender matter in implementation research. BMC Med Res Methodol [Internet]. 2016 Oct 27;16(1):145. Available from: https://pubmed.ncbi.nlm. nih.gov/27788671 73. Pelletier R, Khan NA, Cox J, Daskalopoulou SS, Eisenberg MJ, Bacon SL, et al. Sex Versus GenderRelated Characteristics: Which Predicts Outcome After Acute Coronary Syndrome in the Young? J Am Coll Cardiol. 2016 Jan;67(2):127–35. 74. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014 Nov;29(13):1583–90. 75. Saunders-Pullman R, Wang C, Stanley K, Bressman SB. Diagnosis and referral delay in women with Parkinson’s disease. Gend Med [Internet]. 2011 Jun;8(3):209–17. Available from: https://pubmed. ncbi.nlm.nih.gov/21664587 76. Tosserams A, Araújo R, Pringsheim T, Post B, Darweesh SKL, IntHout J, et al. Underrepresentation of women in Parkinson’s disease trials. Vol. 33, Movement disorders : official journal of the Movement Disorder Society. United States; 2018. p. 1825–6.
RkJQdWJsaXNoZXIy MTk4NDMw